Cook Biotech focuses on advanced tissue-repair products from biomaterials. The acquisition will bolster RTI Surgical’s place as a contract development and manufacturing organization in regenerative medicine.
Cook Biotech’s portfolio leverages the regenerative properties of porcine small intestinal submucosa. Its biomaterials have been used for areas including nerve repair and cardiovascular care.
RTI Surgical’s products have been used for spine and orthopedic applications, along with dental and urology cases.
The transaction is expected to close in the first quarter of this year.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
